Waters Corp. Discloses Pro Forma Financials Post-$16.8B Acquisition, Revealing Significant EPS Drop
Summary
Waters Corporation filed pro forma financial statements for its recently closed $16.8 billion acquisition of BD's Biosciences and Diagnostic Solutions business, showing a substantial increase in revenue but a significant negative impact on pro forma net income and earnings per share.
Key Events
-
Acquisition Financials Released
Waters filed unaudited condensed combined financial statements for the acquired SpinCo Business and pro forma combined financials for the merged entity, following the February 9, 2026, acquisition.
-
Significant Revenue Growth Projected
Pro forma net sales for the combined company are projected to be $6.39 billion for the year ended December 31, 2025, a substantial increase from Waters' historical $3.17 billion.
-
Major EPS Decline Revealed
Pro forma basic earnings per share are projected at $0.63 for the year ended December 31, 2025, a significant decrease from Waters' historical $10.80.
-
Dilution and Ownership Shift Confirmed
The acquisition involved issuing 38.5 million shares, resulting in former BD shareholders owning approximately 39.2% of Waters' common stock on a fully diluted basis.
Analysis
This 8-K provides critical financial details for Waters Corporation's recently completed $16.8 billion acquisition of BD's Biosciences and Diagnostic Solutions (SpinCo) business. While the pro forma statements indicate a substantial increase in revenue for the combined entity, they also reveal a significant negative impact on net income and a drastic reduction in pro forma earnings per share (from $10.80 to $0.63). This financial shift, coupled with the issuance of 39.2% of Waters' common stock to former BD shareholders, fundamentally alters the company's financial profile and investment thesis. Investors will need to carefully assess the integration challenges and the path to profitability for the combined entity, especially given the company is currently trading near its 52-week low.
At the time of this filing, WAT was trading at $285.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $28.1B. The 52-week trading range was $275.05 to $414.15. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.